%0 Journal Article
%T Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancer
%A Nardin, Simone
%A Del Mastro, Lucia
%J Annals of Translational Medicine
%D 2023
%B 2023
%9 
%! Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancer
%K 
%X 
%U https://atm.amegroups.org/article/view/107892
%V 11
%N 5
%P 228
%@ 2305-5847